122 related articles for article (PubMed ID: 29864913)
1. miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10.
Wang X; Li J; Xu X; Zheng J; Li Q
Biomed Pharmacother; 2018 Jul; 103():1312-1318. PubMed ID: 29864913
[TBL] [Abstract][Full Text] [Related]
2. miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA.
Qiao W; Guo B; Zhou H; Xu W; Chen Y; Liang Y; Dong B
Biochem Biophys Res Commun; 2017 Apr; 486(1):43-48. PubMed ID: 28242198
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG7 enhances chemoresistance in neuroblastoma through cisplatin-induced autophagy by regulating miR-329-3p/MYO10 axis.
Wang SY; Wang X; Zhang CY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3805-3817. PubMed ID: 32329857
[TBL] [Abstract][Full Text] [Related]
4. NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10.
Sun Y; Ai X; Shen S; Lu S
Oncotarget; 2015 Apr; 6(10):8244-54. PubMed ID: 25749519
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
Wang Z; Lei H; Sun Q
Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
[TBL] [Abstract][Full Text] [Related]
6. miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3β and SFRP1.
Li Z; Xu Z; Xie Q; Gao W; Xie J; Zhou L
Biomed Pharmacother; 2016 Oct; 83():508-513. PubMed ID: 27434867
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.
Soriano A; París-Coderch L; Jubierre L; Martínez A; Zhou X; Piskareva O; Bray I; Vidal I; Almazán-Moga A; Molist C; Roma J; Bayascas JR; Casanovas O; Stallings RL; Sánchez de Toledo J; Gallego S; Segura MF
Oncotarget; 2016 Feb; 7(8):9271-87. PubMed ID: 26824183
[TBL] [Abstract][Full Text] [Related]
8. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1247 inhibits cell proliferation by directly targeting ZNF346 in childhood neuroblastoma.
Wu T; Lin Y; Xie Z
Biol Res; 2018 May; 51(1):13. PubMed ID: 29793538
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis
Zhao J; Zhou K; Ma L; Zhang H
Bioengineered; 2020 Dec; 11(1):219-228. PubMed ID: 32083506
[TBL] [Abstract][Full Text] [Related]
11. miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1.
Chen S; Jin L; Nie S; Han L; Lu N; Zhou Y
Oncol Res; 2018 Apr; 26(3):445-455. PubMed ID: 28653600
[TBL] [Abstract][Full Text] [Related]
12. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
[TBL] [Abstract][Full Text] [Related]
13. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.
Li Y; Wang H; Li J; Yue W
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):48-55. PubMed ID: 24345480
[TBL] [Abstract][Full Text] [Related]
14. microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma.
He XY; Tan ZL; Mou Q; Liu FJ; Liu S; Yu CW; Zhu J; Lv LY; Zhang J; Wang S; Bao LM; Peng B; Zhao H; Zou L
Clin Cancer Res; 2017 Jun; 23(11):2905-2918. PubMed ID: 28003306
[No Abstract] [Full Text] [Related]
15. miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A.
Yang H; Li Q; Zhao W; Yuan D; Zhao H; Zhou Y
FEBS Lett; 2014 Jan; 588(1):192-7. PubMed ID: 24316513
[TBL] [Abstract][Full Text] [Related]
16. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
17. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
20. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]